Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children

NCT02308527 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

225

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Bevacizumab
DRUG: Temozolomide
DRUG: Temozolomide
DRUG: Irinotecan
DRUG: Bevacizumab
DRUG: Topotecan
DRUG: Temozolomide
DRUG: Dinutuximab Beta
DRUG: Cyclophosphamide

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]